Lynch Ryan
- SEC CIK
- 0001709271
In the past year, 2 open-market sale filings worth $12.7K and no purchases.
Current role at each company
- CBIO Crescent Biopharma, Inc.See Remarksas of Sep 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $12.7K
- 2 filings
- Net
- −$12.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lynch Ryan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 (view filing)4:03 PM ET | Sep 16 | 2 days | Lynch RyanSee Remarks | SSale | −240 | $17.90 | −$4.30K | −1.7%13.6K after | 10b5-1 |
| Jun 23, 2026 (view filing) | Jun 22 | 1 day | Lynch RyanSee Remarks | SSale | −465 | $17.99 | −$8.37K | −3.2%13.9K after | 10b5-1 |